021-51111890
购物车（）
sales@molnova.cn
TRAM-34
CAS No. 289905-88-0
TRAM-34 ( TRAM-34; TRAM34; TRAM 34 )
产品货号. M18371 CAS No. 289905-88-0
TRAM-34(Kd=20 nM), an effective and specific inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1), does not block cytochrome P450.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥348 | 有现货 |
|
| 25MG | ￥656 | 有现货 |
|
| 50MG | ￥1199 | 有现货 |
|
| 100MG | ￥1580 | 有现货 |
|
| 200MG | ￥2049 | 有现货 |
|
| 500MG | ￥3443 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TRAM-34
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述TRAM-34(Kd=20 nM), an effective and specific inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1), does not block cytochrome P450.
-
产品描述TRAM-34 is a highly selective blocker of intermediate conductance Ca2+-activated K+ channels (KCa3.1) (Kd = 20 nM). Exhibits 200-1500-fold selectivity over KV, BKCa, KCa2, Na+, CRAC and Cl- channels. Suppresses the reactivation of lymphocytes by mitogenic stimuli, and does not block cytochrome P450.
-
同义词TRAM-34; TRAM34; TRAM 34
-
通路Others
-
靶点Other Targets
-
受体IKCa1 (KCa3.1)
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number289905-88-0
-
分子量344.84
-
分子式C22H17ClN2
-
纯度98%
-
溶解度DMSO : ≥ 3.5 mg/mL; 10.15 mM
-
SMILESn1(nccc1)C(c1ccccc1)(c1ccccc1)c1c(cccc1)Cl
-
化学全称1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Wulff H, et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8151-6.
产品手册
关联产品
-
BRD7389
BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.
-
Atractyloside A
Atractyloside is a glycoside of a kaurene type diterpene that is found in some plants including Atractylis gummifera (atractylis); coffee; xanthium, and callilepis.
-
TC-A 2317 hydrochlor...
TC-A 2317 hydrochloride is an inhibitor of Aurora kinase A with a Ki of 1.2 nM compared to Aurora kinase B with a Ki of 101 nM. TC-A 2317 hydrochloride shows antitumor activity.
